Literature DB >> 20598454

Conformal radiotherapy in the treatment of advanced juvenile nasopharyngeal angiofibroma with intracranial extension: an institutional experience.

Santam Chakraborty1, Sushmita Ghoshal, Vijay Maruti Patil, Arun Singh Oinam, Suresh C Sharma.   

Abstract

PURPOSE: To describe the results of conformal radiotherapy in advanced juvenile nasopharyngeal angiofibroma in a tertiary care institution. METHODS AND MATERIALS: Retrospective chart review was conducted for 8 patients treated with conformal radiotherapy between 2006 and 2009. The median follow-up was 17 months. All patients had Stage IIIB disease with intracranial extension. Radiotherapy was considered as treatment because patients were deemed inoperable owing to extensive intracranial/intraorbital extension or proximity to optic nerve. All but 1 patient were treated with intensity-modulated radiotherapy using seven coplanar fields. Median (range) dose prescribed was 39.6 (30-46) Gy. Actuarial analysis of local control and descriptive analysis of toxicity profile was conducted.
RESULTS: Despite the large and complex target volume (median planning target volume, 292 cm(3)), intensity-modulated radiotherapy achieved conformal dose distributions (median van't Reit index, 0.66). Significant sparing of the surrounding organs at risk was obtained. No significant Grade 3/4 toxicities were experienced during or after treatment. Actual local control at 2 years was 87.5%. One patient died 1 month after radiotherapy secondary to massive epistaxis. The remaining 7 patients had progressive resolution of disease and were symptom-free at last follow-up. Persistent rhinitis was the only significant toxicity, seen in 1 patient.
CONCLUSIONS: Conformal radiotherapy results in good local control with minimal acute and late side effects in juvenile nasopharyngeal angiofibromas, even in the presence of advanced disease.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20598454     DOI: 10.1016/j.ijrobp.2010.04.048

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

Review 1.  Juvenile Angiofibroma: Current Management Strategies.

Authors:  Ahmad Safadi; Alberto Schreiber; Dan M Fliss; Piero Nicolai
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-18

Review 2.  Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation.

Authors:  Stephanie R McKeown; Paul Hatfield; Robin J D Prestwich; Richard E Shaffer; Roger E Taylor
Journal:  Br J Radiol       Date:  2015-10-14       Impact factor: 3.039

3.  Clinical Characteristics of Recurrent Juvenile Nasopharyngeal Angiofibroma (JNA) After Radiation Therapy.

Authors:  Ozan Gökdoğan; Beyhan Demirhan; Ahmet Koybasioglu; Fikret İleri
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-05-29

4.  Long-term treatment outcomes of juvenile nasopharyngeal angiofibroma treated with radiotherapy.

Authors:  S Mallick; R Benson; S Bhasker; B K Mohanti
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-04       Impact factor: 2.124

5.  Radiation-Induced Sarcoma Originating in Recurrent Juvenile Nasopharyngeal Angiofibroma.

Authors:  Smriti Panda; Madhu Rajeshwari; Chirom Amit Singh; Suresh C Sharma; Pirabu Sakthivel
Journal:  Case Rep Oncol Med       Date:  2018-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.